Target- |
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.United States |
First Approval Date09 May 1997 |
100 Clinical Results associated with Avent, Inc.
0 Patents (Medical) associated with Avent, Inc.
100 Deals associated with Avent, Inc.
100 Translational Medicine associated with Avent, Inc.